Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: the randomized controlled FK04 trial

被引：0
|
作者：
Ruijter, B. [1 ]
Tushuizen, M. [1 ]
Moes, D. -J. [2 ]
de Klerk, B. [1 ]
van Hoek, B. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Gastroenterol & Hepatol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Clin Pharmacol & Toxicol, Leiden, Netherlands
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
EP-295
引用
收藏
页码：215 / 215
页数：1
相关论文
共 45 条
  • [1] Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trial
    Ruijter, Bastian N.
    Tushuizen, Maarten E.
    Moes, Dirk J. A. R.
    de Klerk, Babs M.
    van Hoek, Bart
    CLINICAL TRANSPLANTATION, 2022, 36 (12)
  • [2] A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients
    Shenoy, Surendra
    Hardinger, Karen L.
    Crippin, Jeffrey
    Korenblat, Kevin
    Lisker-Melman, Mauricio
    Lowell, Jeffrey A.
    Chapman, William
    LIVER TRANSPLANTATION, 2008, 14 (02) : 173 - 180
  • [3] Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study
    Ruijter, Bastian N.
    Inderson, Akin
    van den Berg, Aad P.
    Metselaar, Herold J.
    Dubbeld, Jeroen
    Tushuizen, Maarten E.
    Porte, Robert J.
    Polak, Wojciech
    van der Helm, Danny
    van Reeven, Marjolein
    Rodriguez-Girondo, Mar
    van Hoek, Bart
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (04) : 839 - 849
  • [4] C2 monitoring using 4-hour intravenous infusions of cyclosporine in de novo liver transplant recipents
    Nashan, B
    Lück, R
    Böger, J
    Kuse, E
    Klempnauer, J
    LIVER TRANSPLANTATION, 2004, 10 (06) : C39 - C39
  • [5] Significance of trough monitoring of tacrolimus blood concentration and calcineurin activity in living-donor liver transplant patients
    Yano, I
    Masuda, S.
    Egawa, H.
    Sugimoto, Y.
    Fukudo, M.
    Yoshida, Y.
    Yasuda, S.
    Kaido, T.
    Uemoto, S.
    Inui, K.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 529 - 530
  • [6] C2 monitoring using 4-hour intravenous infusions of cyclosporine in de novo liver transplant recipents.
    Lück, R
    Böger, J
    Kuse, E
    Klempnauer, J
    Nashan, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 361 - 361
  • [7] Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients
    Langers, P
    Cremers, SCLM
    den Hartigh, J
    Veenendaal, RA
    ten Hove, WR
    Ringers, J
    Lamers, CBHW
    van Hoek, B
    LIVER TRANSPLANTATION, 2004, 10 (02) : 183 - 189
  • [8] Effects, costs and implementation of monitoring kidney transplant patients' tacrolimus levels with dried blood spot sampling: A randomized controlled hybrid implementation trial
    Veenhof, Herman
    van Boven, Job Frank Martien
    van der Voort, Anna
    Berger, Stefan Philip
    Bakker, Stephanus Johannes Leonardus
    Touw, Daniel Johannes
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (07) : 1357 - 1366
  • [9] Impact of a Pharmaceutical Care Program on Liver Transplant Patients' Compliance With Immunosuppressive Medication: A Prospective, Randomized, Controlled Trial Using Electronic Monitoring
    Klein, Anja
    Otto, Gerd
    Kraemer, Irene
    TRANSPLANTATION, 2009, 87 (06) : 839 - 847
  • [10] The economic impact of immunosuppression using cyclosporine (CSA) with 2 hour post dose monitoring vs. tacrolimus (FK) following de novo liver transplantation - Results of a prospective, randomized trial.
    Shenoy, S
    Hardinger, K
    Laflin, MA
    Kemp, D
    Desai, N
    Lowell, J
    Crippin, J
    Mehlman, ML
    Korenblat, K
    Chapman, W
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 506 - 506
12345